Patent · US Active

Antibody molecule-drug conjugates and uses thereof

US11168131B2 · kind B2 · utility

2Cited by

5References

15Claims

0Family size

Assignee

Visterra, Inc. · US

Inventors

Obadiah J. Plante · Beverly, US
James C. Delaney · Cambridge, US
Karthik Viswanathan · Waltham, US
Boopathy Ramakrishnan · Braintree, US
Zachary Shriver · Winchester, US
Andrew M. Wollacott · Boston, US

Key dates

Filing date	Nov 10, 2016
Grant date	Nov 9, 2021
Priority date	—
Expiry date	Nov 10, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS) are disclosed. The antibody molecule-drug conjugates can be used to treat, prevent, and/or diagnose bacterial infections and related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.